DPP4 and breast angiosarcoma: While our finding of a modest CD26 upregulation on αβ T cells during disease progression is consistent with previous studies demonstrating CD26 regulation on αβ T cells in autoimmune and inflammatory models36,37these results suggest that more relevant regulatory shifts in CD26 expression in BA are likely driven by other T cell subsets, such as γδ T cells.